TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
-21.06%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$245M
AUM Growth
+$245M
(-30%)
Cap. Flow
-$36.6M
Cap. Flow
% of AUM
-14.95%
Top 10 Holdings %
Top 10 Hldgs %
79.7%
Holding
31
New
2
Increased
11
Reduced
4
Closed
6
Top Buys
| 1 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$10.6M |
| 2 |
AtriCure
ATRC
|
$9.95M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$7.81M |
| 4 |
McKesson
MCK
|
$5.52M |
| 5 |
Service Corp International
SCI
|
$2.46M |
Top Sells
| 1 |
Labcorp
LH
|
$27.8M |
| 2 |
CORI
Corium International, Inc.
CORI
|
$13.6M |
| 3 |
Gilead Sciences
GILD
|
$13.5M |
| 4 |
Pacira BioSciences
PCRX
|
$7.37M |
| 5 |
Hologic
HOLX
|
$6.17M |
Sector Composition
| 1 | Healthcare | 84.77% |
| 2 | Industrials | 6.36% |
| 3 | Consumer Discretionary | 4.52% |
| 4 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1
DELISTED
Veradigm Inc. Common Stock
MDRX
| $29.4M | 11.99% | 3,050,000 +1,100,000 | +56% | +$10.6M |
|
2
Medtronic
MDT
$119B
| $25M | 10.2% | 275,000 +15,000 | +6% | +$1.36M |
|
|
NUVA
3
DELISTED
NuVasive, Inc.
NUVA
| $24.8M | 10.1% | 500,000 -25,000 | -5% | -$1.24M |
|
4
NovoCure
NVCR
$1.38B
| $22.4M | 9.15% | 670,000 +35,000 | +6% | +$1.17M |
|
|
5
AtriCure
ATRC
$1.84B
| $18.4M | 7.49% | 600,000 +325,000 | +118% | +$9.95M |
|
|
NXTM
6
DELISTED
NxStage Medical Inc.
NXTM
| $17.9M | 7.29% | 625,000 +25,000 | +4% | +$716K |
|
|
SRCL
7
DELISTED
Stericycle Inc
SRCL
| $15.6M | 6.36% | 425,000 +55,000 | +15% | +$2.02M |
|
8
Lantheus
LNTH
$3.73B
| $15.3M | 6.22% | 975,000 +5,000 | +0.5% | +$78.3K |
|
9
Bio-Rad Laboratories Class A
BIO
$8.06B
| $13.9M | 5.68% | 60,000 -5,000 | -8% | -$1.16M |
|
10
Rigel Pharmaceuticals
RIGL
$697M
| $12.7M | 5.16% | 5,500,000 +950,000 | +21% | +$2.19M |
|
|
11
Service Corp International
SCI
$11.1B
| $11.1M | 4.51% | 275,000 +61,144 | +29% | +$2.46M |
|
|
12
Hologic
HOLX
$14.9B
| $8.22M | 3.35% | 200,000 -150,000 | -43% | -$6.17M |
|
|
PTLA
13
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $7.81M | 3.18% | +400,000 | New | +$7.81M |
|
|
14
McKesson
MCK
$85.4B
| $5.52M | 2.25% | +50,000 | New | +$5.52M |
|
|
CORV
15
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $5.29M | 2.16% | 2,125,000 +65,000 | +3% | +$162K |
|
|
HIND
16
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $4.35M | 1.77% | 2,100,000 | – | – |
|
|
VSI
17
DELISTED
Vitamin Shoppe Inc.
VSI
| $2.84M | 1.16% | 600,000 | – | – |
|
|
OPTN
18
DELISTED
OptiNose
OPTN
| $1.86M | 0.76% | 300,000 -560,000 | -65% | -$3.47M |
|
|
STRM
19
DELISTED
Streamline Health Solutions
STRM
| $1.58M | 0.64% | 1,950,000 +50,000 | +3% | +$40.5K |
|
|
ISEE
20
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.2M | 0.49% | 1,000,000 | – | – |
|
21
Alkermes
ALKS
$4.78B
| – | – | 0 | – | – |
|
22
Amgen
AMGN
$155B
| – | – | 0 | – | – |
|
|
23
Gilead Sciences
GILD
$140B
| – | – | -175,000 | Closed | -$13.5M |
|
24
Glaukos
GKOS
$5.5B
| – | – | -75,000 | Closed | -$4.87M |
|
|
25
Labcorp
LH
$23.1B
| – | – | -160,000 | Closed | -$27.8M |
|